Saturday, June 6, 2020

Tag: Indego Exoskeleton

FDA Clears Parker’s Indego® Exoskeleton for Clinical, Personal Use

Published: March 10, 2016

Indego exoskeleton userState-of-the-Art Device Allows Individuals with Spinal Cord Injury to Stand and Walk; Regulatory Clearances in USA and Europe Pave the Way for Commercialization

CLEVELAND, March 10, 2016 (GLOBE NEWSWIRE) — Parker Hannifin Corporation (NYSE: PH), the global leader in motion and control technologies, today announced that the U.S. Food and Drug Administration (FDA) has given clearance to market and sell the Indego® exoskeleton for clinical and personal use in the United States. The company intends to commercially launch the device in the United States in the coming months.

Do NOT follow this link or you will be banned from the site!